Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to $12.5 million.

  • Bio-Techne's Dividends Paid - Common fell 208.86% to $12.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $49.9 million, marking a year-over-year decrease of 147.94%. This contributed to the annual value of $50.4 million for FY2025, which is 5.55% down from last year.
  • Per Bio-Techne's latest filing, its Dividends Paid - Common stood at $12.5 million for Q4 2025, which was down 208.86% from $12.4 million recorded in Q3 2025.
  • In the past 5 years, Bio-Techne's Dividends Paid - Common ranged from a high of $12.7 million in Q4 2024 and a low of $12.4 million during Q2 2025
  • For the 5-year period, Bio-Techne's Dividends Paid - Common averaged around $12.6 million, with its median value being $12.6 million (2021).
  • As far as peak fluctuations go, Bio-Techne's Dividends Paid - Common soared by 155.0% in 2021, and later plummeted by 208.86% in 2025.
  • Bio-Techne's Dividends Paid - Common (Quarter) stood at $12.6 million in 2021, then fell by 0.12% to $12.6 million in 2022, then dropped by 0.02% to $12.6 million in 2023, then increased by 1.41% to $12.7 million in 2024, then fell by 2.09% to $12.5 million in 2025.
  • Its last three reported values are $12.5 million in Q4 2025, $12.4 million for Q3 2025, and $12.4 million during Q2 2025.